Ipsen’s partner Exelixis announces clinical collaboration with Bristol Myers Squibb for late-stage combination trial in first-line renal cell carcinoma.

Fulfilling our commitment to employees and mission to patients in the context of the COVID-19 pandemic

International Women’s Day 2020: For real equality!

Celebrating Ipsen Rare Disease Day 2020

FY2019 and beyond: paving the way for our next phase of growth.